Verition Fund Management’s Nektar Therapeutics NKTR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-116,238
| Closed | -$1.04M | – | 2111 |
|
|
2023
Q3 | $1.04M | Buy |
116,238
+110,238
| +1,837% | +$985K | 0.01% | 903 |
|
|
2023
Q2 | $51.8K | Buy |
+6,000
| New | +$51.8K | ﹤0.01% | 1756 |
|
|
2022
Q4 | – | Sell |
-783
| Closed | -$38K | – | 2013 |
|
|
2022
Q3 | $38K | Hold |
783
| – | – | ﹤0.01% | 2107 |
|
|
2022
Q2 | $45K | Buy |
783
+101
| +15% | +$5.81K | ﹤0.01% | 2073 |
|
|
2022
Q1 | $55K | Buy |
+682
| New | +$55K | ﹤0.01% | 1687 |
|
|
2020
Q1 | – | Sell |
-1,295
| Closed | -$419K | – | 803 |
|
|
2019
Q4 | $419K | Buy |
+1,295
| New | +$419K | 0.01% | 625 |
|
|
2019
Q3 | – | Sell |
-477
| Closed | -$254K | – | 1109 |
|
|
2019
Q2 | $254K | Buy |
+477
| New | +$254K | 0.01% | 813 |
|
|
2018
Q4 | – | Sell |
-303
| Closed | -$277K | – | 1028 |
|
|
2018
Q3 | $277K | Buy |
+303
| New | +$277K | 0.01% | 986 |
|
|
2018
Q2 | – | Sell |
-1,298
| Closed | -$2.07M | – | 1166 |
|
|
2018
Q1 | $2.07M | Buy |
+1,298
| New | +$2.07M | 0.15% | 123 |
|